• China Longevity Group posted a 22.7% rise in profit attributable to owners to RMB 21.1 million, lifting basic EPS to RMB 0.0247.
• Revenue rose 9.2% to RMB 646.1 million, while gross margin fell 1.4 percentage points to 15.6% on higher Material Products costs.
• Operating profit climbed to RMB 34.5 million, as selling and distribution costs fell to RMB 15.4 million amid lower agency service fees.
• Material Products revenue increased to RMB 598.8 million, with Building Material Products up to RMB 47.3 million; PRC sales rose to RMB 453.4 million.
• Finance costs increased to RMB 11.1 million on higher bank borrowings; the board declared no interim dividend.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Longevity Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309060), on August 31, 2026, and is solely responsible for the information contained therein.